Which has the lower trailing P/E, ICUI or INDV?

INDV has the lower trailing P/E: ICUI trades at 134.03 and INDV at 12.61. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ICUI or INDV?

Over the past five years, INDV grew revenue faster — ICUI at a 11.05% CAGR versus INDV at 13.88%.

Does ICUI or INDV pay a bigger dividend?

INDV pays a dividend (1.32% yield), while ICUI has no payments in the available dividend history.

Is ICUI or INDV more profitable?

INDV runs the higher net margin — ICUI at 1.39% versus INDV at 26.65%.

How have ICUI and INDV total returns compared?

Over the past 10 years, ICUI delivered 2.51% and INDV delivered 6.16% annualized total return. Past performance doesn't predict future results.

ICU Medical, Inc. (ICUI) vs Indivior Pharmaceuticals Inc (INDV)

A side-by-side comparison of ICU Medical, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ICUI

ICU Medical, Inc.

$3.95B

$158.16HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

INDV

Indivior Pharmaceuticals Inc

$4.39B

$35.19HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

Total return — ICUI vs INDV

growth of $100 · dividends reinvested · last 10y

ICUI +28.4% (+2.5%/yr)INDV +79.3% (+6.0%/yr)INDV compounded faster over this window

ICUI INDV

ICUI vs INDV: by the numbers

•INDV is the larger company ($4.39B vs $3.95B market cap).
•INDV trades at the lower trailing earnings multiple (12.61 vs 134.03 P/E), one valuation lens rather than an overall verdict.
•INDV converts more revenue to profit (26.65% vs 1.39% net margin).
•INDV grew revenue faster over the past five years (13.88% vs 11.05% CAGR).
•INDV pays a dividend (1.32% yield), while ICUI has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ICUI	INDV
P/E ratio	134.03	12.61
Forward P/E	N/A	8.34
P/S ratio	1.83	3.30
P/B ratio	1.84	N/A
EV / EBITDA	13.55	8.78
FCF yield	3.87%	N/A

Profitability

Metric	ICUI	INDV
Gross margin	37.56%	83.86%
Operating margin	5.04%	21.39%
Net margin	1.39%	26.65%
ROE	1.40%	N/A
ROIC	3.11%	N/A

Dividends

Metric	ICUI	INDV
Dividend yield	N/A	1.32%
Payout ratio	N/A	17.03%

Growth (annualized)

Metric	ICUI	INDV
Revenue CAGR (5Y)	11.05%	13.88%
EPS CAGR (5Y)	-62.79%	N/A
FCF CAGR (5Y)	-2.65%	N/A
Total return CAGR (5Y)	-7.18%	19.65%

Frequently asked

Which has the lower trailing P/E, ICUI or INDV?: INDV has the lower trailing P/E: ICUI trades at 134.03 and INDV at 12.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ICUI or INDV?: Over the past five years, INDV grew revenue faster — ICUI at a 11.05% CAGR versus INDV at 13.88%.
Does ICUI or INDV pay a bigger dividend?: INDV pays a dividend (1.32% yield), while ICUI has no payments in the available dividend history.
Is ICUI or INDV more profitable?: INDV runs the higher net margin — ICUI at 1.39% versus INDV at 26.65%.
How have ICUI and INDV total returns compared?: Over the past 10 years, ICUI delivered 2.51% and INDV delivered 6.16% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ICUI analysis Full INDV analysis Interactive comparison tool

Dig into the metrics

ICU Medical P/E ratio Indivior Pharmaceuticals P/E ratio Indivior Pharmaceuticals dividend yield ICU Medical ROE Indivior Pharmaceuticals ROE ICU Medical operating margin Indivior Pharmaceuticals operating margin ICU Medical revenue growth Indivior Pharmaceuticals revenue growth ICU Medical free cash flow Indivior Pharmaceuticals free cash flow

ICU Medical & Indivior Pharmaceuticals appear in these rankings

Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.